Envestnet Asset Management Inc. increased its holdings in Ventas, Inc. (NYSE:VTR – Get Rating) by 66.3% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 369,792 shares of the real estate investment trust’s stock after buying an additional 147,491 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Ventas were worth $22,838,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of VTR. Riverview Trust Co bought a new stake in Ventas in the 1st quarter worth about $25,000. US Asset Management LLC bought a new stake in Ventas in the 1st quarter worth about $32,000. West Bancorporation Inc. bought a new stake in shares of Ventas during the 1st quarter valued at about $33,000. CENTRAL TRUST Co grew its stake in shares of Ventas by 2,053.8% during the 1st quarter. CENTRAL TRUST Co now owns 560 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 534 shares during the period. Finally, MUFG Americas Holdings Corp grew its stake in shares of Ventas by 60.0% during the 4th quarter. MUFG Americas Holdings Corp now owns 768 shares of the real estate investment trust’s stock valued at $39,000 after purchasing an additional 288 shares during the period. 94.02% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
VTR has been the subject of a number of recent research reports. Capital One Financial initiated coverage on Ventas in a research note on Friday, June 3rd. They set an “overweight” rating and a $63.00 price target for the company. Credit Suisse Group initiated coverage on Ventas in a research note on Wednesday, June 22nd. They set an “outperform” rating and a $63.00 price target for the company. Deutsche Bank Aktiengesellschaft cut their price target on Ventas from $67.00 to $65.00 and set a “buy” rating for the company in a research note on Wednesday, July 13th. Mizuho lowered their price objective on Ventas from $65.00 to $61.00 and set a “buy” rating on the stock in a research report on Friday, July 1st. Finally, Morgan Stanley lowered their price objective on Ventas from $59.00 to $52.00 and set an “equal weight” rating on the stock in a research report on Friday, July 15th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, Ventas presently has an average rating of “Moderate Buy” and a consensus price target of $61.80.
Ventas Stock Performance
Ventas Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, July 14th. Investors of record on Friday, July 1st were paid a dividend of $0.45 per share. The ex-dividend date of this dividend was Thursday, June 30th. This represents a $1.80 annualized dividend and a yield of 3.45%. Ventas’s payout ratio is 461.55%.
Insider Activity at Ventas
In other Ventas news, CEO Debra A. Cafaro sold 17,400 shares of Ventas stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $56.43, for a total value of $981,882.00. Following the completion of the transaction, the chief executive officer now directly owns 767,960 shares of the company’s stock, valued at approximately $43,335,982.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is currently owned by corporate insiders.
Ventas Company Profile
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.
- Get a free copy of the StockNews.com research report on Ventas (VTR)
- AMD Q2 Earnings Beat Expectations Significantly, Is AMD A Buy?
- 3 Health Care Stocks in Great Financial Health
- Amazon Names Itself A Top Stock Of Q3 Contender
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Pinterest Shares Are Soaring After Earnings, Is The Stock A Buy?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.